Group structure
6 companies in 2 countries
Canada1
United Kingdom1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading…
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 32
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMINOPHYLLIN25mg/ml · Injectable | Aminophylline | United States | Not marketed | 1982 |
| AMINOPHYLLIN100mg | 200mg · Tablet | Aminophylline | United States | Not marketed | 1940 |
| AMMONIUM CHLORIDE3meq/ml | 5meq/ml · Injectable | Ammonium | United States | Not marketed | 1973 |
| BEXTRA10mg | 20mg · Tablet | Valdecoxib | United States | Not marketed | 2001 |
| CALAN2.5mg/ml · Injectable | Verapamil | United States | Not marketed | 1984 |
| CU-789mg · Intrauterine device | Copper | United States | Not marketed | |
| DEMULEN 1/35-210.035MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Not marketed | 1981 |
| DEMULEN 1/35-280.035MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Not marketed | 1981 |
| DEMULEN 1/50-210.05mg; 1mg · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Not marketed | 1970 |
| DEMULEN 1/50-280.05MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Ethynodiol diacetate | United States | Not marketed | 1970 |
| DIULO10mg | 2.5mg | 5mg · Tablet | Metolazone | United States | Not marketed | 1981 |
| ENOVID0.075mg; 5mg · Tablet | Mestranol, Norethynodrel | United States | Not marketed | 1961 |
| ENOVID0.075mg; 5mg | 0.15mg; 9.85mg · Tablet | Mestranol, Norethynodrel | United States | Not marketed | 1961 |
| ENOVID-E0.1mg; 2.5mg · Tablet | Mestranol, Norethynodrel | United States | Not marketed | 1961 |
| ENOVID-E 210.1mg; 2.5mg · Tablet | Mestranol, Norethynodrel | United States | Not marketed | 1961 |
| LOMOTIL0.025mg/5ml; 2.5mg/5ml · Solution | Atropine, Diphenoxylate | United States | Not marketed | 1961 |
| NORINYL 1+80 21-DAY0.08mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1968 |
| NORINYL 1+80 28-DAY0.08mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1968 |
| NORMINEST FE0.035mg; 0.5mg; 75mg · Tablet | Ethinyl estradiol, Norethindrone, Ferrous | United States | Marketed | 1978 |
| OVULEN1mg; 0.1mg · Tablet | Ethynodiol diacetate, Mestranol | United States | Not marketed | 1966 |
| OVULEN-211mg; 0.1mg · Tablet | Ethynodiol diacetate, Mestranol | United States | Not marketed | 1966 |
| OVULEN-281mg; 0.1mg · Tablet | Ethynodiol diacetate, Mestranol | United States | Not marketed | 1967 |
| PRO-BANTHINE30mg/vial · Injectable | Propantheline | United States | Not marketed | |
| TATUM-T120mg · Intrauterine device | Copper | United States | Not marketed | |
| ALDACTIDE-25 TAB | Hydroflumethiazide, Spironolactone | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 24 | 24 | 0 | CompaniesAll medicines |
| Saudi Arabia | 7 | 7 | 0 | CompaniesAll medicines |
| Canada | 1 | 0 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Keep Searle’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.